From the Department of Nephrology, Sri Venkateswar Institute of Medical Sciences, Tirupati, India.
Exp Clin Transplant. 2020 Feb;18(1):110-111. doi: 10.6002/ect.2017.0114. Epub 2018 Jul 2.
Early trials of tacrolimus in renal transplant recipients have not revealed hearing loss as an adverse effect. Here, we present a case report and a review of the literature of deafness after tacrolimus use. The review of the literature and our experience suggested that the possible reason for hearing loss could be due to an initiation of a sudden spike in the tacrolimus serum level, which was later worsened by its cumulative toxic effect.
早期肾移植受者使用他克莫司的试验并未显示听力损失是一种不良反应。在此,我们报告 1 例病例并对使用他克莫司后发生耳聋的文献进行了回顾。文献复习和我们的经验表明,听力损失的可能原因是他克莫司血清水平突然升高,随后其累积毒性作用使其恶化。